2 results
Approved WMOCompleted
Primary: to estimate progression-free survival in patients treated with everolimus + letrozole in the first line setting.Secondary: overall response rate, clinical benefit rate, overall survival in the first line setting, progression free survival…
Approved WMORecruiting
To assess if PCI optimization using High Definition (HD)-IVUS in patients with a post-PCI FFR below 0.90 will improve target vessel failure.